213 related articles for article (PubMed ID: 34203430)
21. Influence of Recombinant Codon-Optimized Plasmid DNA Encoding VEGF and FGF2 on Co-Induction of Angiogenesis.
Salafutdinov II; Gazizov IM; Gatina DK; Mullin RI; Bogov AA; Islamov RR; Kiassov AP; Masgutov RF; Rizvanov AA
Cells; 2021 Feb; 10(2):. PubMed ID: 33670607
[TBL] [Abstract][Full Text] [Related]
22. VEGF inhibitors for the treatment of neovascular age-related macular degeneration.
Barakat MR; Kaiser PK
Expert Opin Investig Drugs; 2009 May; 18(5):637-46. PubMed ID: 19388880
[TBL] [Abstract][Full Text] [Related]
23. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
[TBL] [Abstract][Full Text] [Related]
24. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review).
Katoh M
Int J Mol Med; 2013 Oct; 32(4):763-7. PubMed ID: 23863927
[TBL] [Abstract][Full Text] [Related]
25. ATP-dependent stabilization and protection of fibroblast growth factor 2.
Rose K; Gast RE; Seeger A; Krieglstein J; Klumpp S
J Biotechnol; 2010 Jan; 145(1):54-9. PubMed ID: 19836424
[TBL] [Abstract][Full Text] [Related]
26. Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF.
Zubilewicz A; Hecquet C; Jeanny JC; Soubrane G; Courtois Y; Mascarelli F
Oncogene; 2001 Mar; 20(12):1403-13. PubMed ID: 11313884
[TBL] [Abstract][Full Text] [Related]
27. Nucleic acid aptamers: clinical applications and promising new horizons.
Ni X; Castanares M; Mukherjee A; Lupold SE
Curr Med Chem; 2011; 18(27):4206-14. PubMed ID: 21838685
[TBL] [Abstract][Full Text] [Related]
28. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
Sorrentino C; Miele L; Porta A; Pinto A; Morello S
Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
[TBL] [Abstract][Full Text] [Related]
29. Complement-mediated release of fibroblast growth factor 2 from human RPE cells.
Yang P; Neal SE; Buehne KL; Tewkesbury GM; Klingeborn M; Yang YY; Baciu P; Jaffe GJ
Exp Eye Res; 2021 Mar; 204():108471. PubMed ID: 33516764
[TBL] [Abstract][Full Text] [Related]
30. Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation.
Zheng J; Wen Y; Song Y; Wang K; Chen DB; Magness RR
Biol Reprod; 2008 Jan; 78(1):143-50. PubMed ID: 17901071
[TBL] [Abstract][Full Text] [Related]
31. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2014 Aug; 8(8):CD005139. PubMed ID: 25170575
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.
Ritter E; Perry A; Yu J; Wang T; Tang L; Bieberich E
Ann Surg; 2008 Feb; 247(2):310-4. PubMed ID: 18216538
[TBL] [Abstract][Full Text] [Related]
33. Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor.
Ferreras C; Rushton G; Cole CL; Babur M; Telfer BA; van Kuppevelt TH; Gardiner JM; Williams KJ; Jayson GC; Avizienyte E
J Biol Chem; 2012 Oct; 287(43):36132-46. PubMed ID: 22927437
[TBL] [Abstract][Full Text] [Related]
34. Influence of Strontium on Vascular Endothelial Growth Factor and Fibroblast Growth Factor 2 Expression in Rat Chondrocytes Cultured In Vitro.
Zhu X; Kong Y; Huang Y; Zhao B; Wang J
Biol Trace Elem Res; 2019 Aug; 190(2):466-471. PubMed ID: 30414002
[TBL] [Abstract][Full Text] [Related]
35. Heparin-Based Coacervate of FGF2 Improves Dermal Regeneration by Asserting a Synergistic Role with Cell Proliferation and Endogenous Facilitated VEGF for Cutaneous Wound Healing.
Wu J; Ye J; Zhu J; Xiao Z; He C; Shi H; Wang Y; Lin C; Zhang H; Zhao Y; Fu X; Chen H; Li X; Li L; Zheng J; Xiao J
Biomacromolecules; 2016 Jun; 17(6):2168-77. PubMed ID: 27196997
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor 2-functionalized collagen matrices for skeletal muscle tissue engineering.
Yun YR; Lee S; Jeon E; Kang W; Kim KH; Kim HW; Jang JH
Biotechnol Lett; 2012 Apr; 34(4):771-8. PubMed ID: 22160363
[TBL] [Abstract][Full Text] [Related]
37. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis.
Rusnati M; Camozzi M; Moroni E; Bottazzi B; Peri G; Indraccolo S; Amadori A; Mantovani A; Presta M
Blood; 2004 Jul; 104(1):92-9. PubMed ID: 15031207
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice.
van Wijngaarden P; Qureshi SH
Clin Exp Optom; 2008 Sep; 91(5):427-37. PubMed ID: 18637105
[TBL] [Abstract][Full Text] [Related]
39. [Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series].
Meyer CH; Helb HM; Eter N
Ophthalmologe; 2008 Feb; 105(2):125-38, 140-2. PubMed ID: 18256841
[TBL] [Abstract][Full Text] [Related]
40. A computational model of fibroblast growth factor-2 binding to endothelial cells under fluid flow.
Patel NS; Reisig KV; Clyne AM
Ann Biomed Eng; 2013 Jan; 41(1):154-71. PubMed ID: 22825797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
